Ultiva and Oedema - a phase IV clinical study of FDA data

Summary:

Oedema is reported as a side effect among people who take Ultiva (remifentanil hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Noxafil, and have Anaesthesia.

The phase IV clinical study analyzes which people have Oedema when taking Ultiva. It is created by eHealthMe based on reports of 1,668 people who have side effects when taking Ultiva from the FDA, and is updated regularly.

What is Ultiva?

Ultiva has active ingredients of remifentanil hydrochloride. eHealthMe is studying from 1,671 Ultiva users. Check the latest studies of Ultiva.

What is Oedema?

Oedema (fluid collection in tissue) is found to be associated with 2,169 drugs and 2,311 conditions by eHealthMe. Check the latest studies of Oedema.

On Jul, 20, 2026

1,668 people reported to have side effects when taking Ultiva.
Among them, 14 people (0.84%) have Oedema.

Among these 14 people:

How long have people been on Ultiva when they have Oedema? *

What is the gender of people who have Oedema when taking Ultiva? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Oedema when taking Ultiva? *

What are other drugs people take besides Ultiva? *

What are other side effects people have besides Oedema? *

Acute Kidney Failure: 7 people, 50.00%
Rashes (redness): 7 people, 50.00%
Erythema Multiforme (a type of hypersensitivity reaction): 5 people, 35.71%
Haematuria (presence of blood in urine): 5 people, 35.71%
Multi-Organ Failure (multisystem organ failure): 4 people, 28.57%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 4 people, 28.57%
Graft Versus Host Disease In Intestine (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body and damages intestinal mucosal membrane): 4 people, 28.57%
Hypotension (abnormally low blood pressure): 4 people, 28.57%
Hepatitis Fulminant (life-threatening condition defined by significantly impaired liver function): 4 people, 28.57%
Arrhythmias (irregular heartbeat): 3 people, 21.43%

What are the existing conditions these people have? *

Anaesthesia: 5 people, 35.71%
Pain: 2 people, 14.29%
Sedation: 2 people, 14.29%
Venoocclusive Disease (small veins in the liver are obstructed): 1 person, 7.14%
Haematuria (presence of blood in urine): 1 person, 7.14%
Antithrombin Iii Deficiency (rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism, and repetitive intrauterine fetal death (iufd)): 1 person, 7.14%
Blood Lactate Dehydrogenase Increased: 1 person, 7.14%
Cardiac Failure: 1 person, 7.14%
Fever: 1 person, 7.14%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ultiva and have Oedema?

- Check whether Oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultiva:

Ultiva (1,671 reports)

Oedema treatments and more:

Oedema (78,747 reports)

Browse all side effects of Ultiva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema:

Oedema (2,169 drugs)

Browse all the conditions that are associated with Oedema:

Oedema (2,311 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on remifentanil hydrochloride (the active ingredients of Ultiva) and Ultiva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.